Medico Remedies Ltd

Medico Remedies Ltd | Sector: Pharmaceuticals | ISIN: INE630Y01016

₹ 80.95 (1.38%) icon

24 Mar, 2023, 11:02:34 AM
Open
₹ 83.20
Prev. Close
₹ 79.85
Turnover(lac)
₹ 199.48
Day's High
₹ 83.80
Day's Low
₹ 80.70
52 Wk High
₹ 87.75
52 Wk Low
₹ 16.52
Book Value
₹ 5.16
Face Value
₹ 2.00
Mkt. Cap (Cr.)
₹ 671.76
P/E
90.51
EPS
0.89
Div. Yield
0.00

KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 3/24/2023 11:02:34 AM

    ₹ 80.95 1.10 1.38
  • Open
  • ₹ 83.2
  • Prev. Close
  • ₹ 79.85
  • Turnover(Lac.)
  • ₹ 199
  • Day's High
  • ₹ 83.8
  • Day's Low
  • ₹ 80.7
  • 52 Week's High
  • ₹ 87.75
  • 52 Week's Low
  • ₹ 16.52
  • Book Value
  • ₹ 5.16
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 671.76
  • P/E
  • 90.51
  • EPS
  • 0.89
  • Divi. Yield
  • 0

Corporate Actions

02 Feb , 2023

12:00 AM

02 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Feb , 2023

12:00 AM

13 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Nov , 2022

12:00 AM

04 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Sep , 2022

12:00 AM

AGM

Announcement date: 01 Sep , 2022

View Details

04 Aug , 2022

12:00 AM

04 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

12 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Sep , 2022

12:00 AM

BookCloser

View Details

SHAREHOLDING SNAPSHOT
24 March , 2023 | 11:03 AM

PROMOTER - TOTAL73.34%

Indian: 73.34%

Foreign: 0%

NON-PROMOTER - TOTAL 26.66%

Institutions: 0.00%

Non-Institutions: 26.66%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Medico Remedies Ltd News and Update

Image not found
  • 4 hours ago |
  • 4:03 PM

According to a BSE filing, the parties to the proposed transaction, for which a legally binding memorandum of understanding had previously been signed, had "executed a Share Purchase Agreement and finalized the transaction."

Article Image
  • IIFL News Service |
  • 1 day ago |
  • 4:02 PM
ad IconAd Image

FINANCIALS

No Data Available To Display Chart

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Medico Remedies Ltd

  • Haresh Mehta

  • Chairman & Wholetime Director
  • Harshit Mehta

  • Managing Director
  • Rita Mehta

  • Whole-time Director
  • Rishit Mehta

  • Whole-time Director
  • Deepak Vekaria

  • Independent Director
  • Ramesh Rughani

  • Independent Director
  • Bharat Rathod

  • Independent Director
  • Dinesh Modi

  • Company Secretary
  • Deepesh Shah

  • Independent Director

Summary

Medico Remedies Limited was incorporated as a private limited company with the name Medico Remedies Private Limited on March 18, 1994. The status of the Company was changed to a public limited company and the name of the Company was changed to Medico Remedies Limited on March 6, 2017. Medico Remedies is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements. Further in addition to the above, the Company also has manufacturing and marketing capabilities in other drugs such as NSAIDS, antihistaminic, antidiabetics, cardio vascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream & gel for various therapeutic segments.The Company began its operations in the year 1994 with manufacturing and servicing of diuretics, anti-malarials, NSAIDS tablets, anti-reterovirals, anti-ulcer drugs and anti-acids tablets. Over the years the company has expanded its scale and scope of operations and currently the Company is engaged in manufacture of formulations for various medicines. As part of this expansion, in the year 1999 & 2002, the company has acquired two adjacent plots of 1,023.50 sq. metres each respectively, for setting up the plant at Palghar, Maharashtra. The plant is divided into two units, i.e. general formulations unit and betalactam... Read More


Reports by Medico Remedies Ltd


Reports by Medico Remedies Ltd